NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway

Nature Immunology

Volumn 4, Issue 6, 2003, Pages 557-564

  Billadeau, Daniel D ^a,b   Upshaw, Jadee L ^b   Schoon, Renee A ^b   Dick, Christopher J ^b   Leibson, Paul J ^b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GUANOSINE TRIPHOSPHATASE; LIGAND; NATURAL KILLER CELL RECEPTOR NKG2D; PHOSPHATIDYLINOSITOL KINASE; PHOSPHOLIPASE C; PROTEIN DAP10; PROTEIN TYROSINE KINASE; RECEPTOR PROTEIN; RHO FACTOR; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ANTIGEN RECOGNITION; ARTICLE; CANCER CELL; CELL KILLING; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOPLASM; DOWNSTREAM PROCESSING; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; MOLECULAR MECHANICS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MOTIF; SIGNAL TRANSDUCTION; VIRUS INFECTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AMINO ACID MOTIFS; ANIMALS; CELL CYCLE PROTEINS; CYTOTOXICITY, IMMUNOLOGIC; ENZYME PRECURSORS; HUMANS; IMMUNOBLOTTING; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JURKAT CELLS; KILLER CELLS, NATURAL; MEMBRANE PROTEINS; MICE; PHOSPHOLIPASE C; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-VAV; RECEPTORS, IMMUNOLOGIC; RHO GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS;

EID: 0037600740     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni929     Document Type: Article

References (39)

1. Moretta, A. et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19, 197-223 (2001).
2. Cerwenka, A. & Lanier, L.L. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 1, 41-49 (2001).
3. Colucci, F., DiSanto, J.P. & Leibson, P.J. Natural killer cell activation in mice and men: different triggers for similar weapons? Nat. Immunol. 3, 807-813 (2002).
4. Bauer, S. et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 272-729 (1999).
5. Cerwenka, A. et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12, 721-727 (2000).
6. Diefenback, A., Jamieson, A.M., Liu, S.D., Shastr, N. & Raulet, D.H. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1, 119-126 (2000).
7. Cosman, D. et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14, 123-133 (2001).
8. Carayannopoulos, L.N., Naidenko, O.V., Fremont, D.H. & Yokoyama, W.M. Cutting edge: murine UL16-binding protein-like transcript 1: A newly described transcript encoding a high-affinity ligand for murine NKG2D. J. Immunol. 169, 4079-4083 (2002).
9. Lanier, L.L. A renaissance for the tumor immunosurveillance hypothesis. Nat. Med. 7, 1178-1180 (2001).
10. Wu, J. et al. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 285, 730-732 (1999).
11. Diefenbach, A. et al. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat. Immunol. 3, 1142-1149 (2002).
12. Gilfillan, S., Ho, E.L., Cella, M., Yokoyama, W.M. & Colonna, M. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat. Immunol. 3, 1150-1155 (2002).
13. Straus, D.B. & Weiss, A. Genetic evidence for the involvement of the Lck tyrosine kinase in signal transduction through the cell antigen receptor. Cell 70, 585-593 (1992).
14. Williams, B.L. et al. Genetic evidence for differential coupling of Syk family kinases to the T-cell receptor: reconstitution studies in a ZAP-70-deficient Jurkat T-cell line. Mol. Cell. Biol. 18, 1388-1399 (1998).
15. Binstadt, B.A. et al. SLP-76 is a direct substrate of SHP-1 recruited to killer cell inhibitory receptors. J. Biol. Chem. 273, 27518-27523 (1998).
16. Jevremovic, D. et al. Cutting edge: a role for the adaptor protein LAT in human NK cell-mediated cytotoxicity. J. Immunol. 162, 2453-2456 (1999).
17. Lanier, L.L., Corliss, B.C., Wu, J., Leong, C. & Phillips, J.H. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391, 703-707 (1998).
18. Billadeau, D.D. & Leibson, P.J. ITAMs versus ITIMs: striking a balance during cell regulation. J. Clin. Invest. 109, 161-168 (2002).
19. Chambers, B.J., Salcedo, M. & Ljunggren, H.-G. Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity 5, 311-317 (1996).
20. Azuma, M., Cayabyab, M., Buck, D., Phillips, J.H. & Lanier, L.L. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. J. Immunol. 149, 1115-1123 (1992).
21. Ogasawara, K., Yoshinaga, S.K. & Lanier, L.L. Inducible costimulator costimulates cytotoxic activity and IFN-γ production in activated murine NK cells. J. Immunol. 169, 3676-3685 (2002).
22. Wu, J., Cherwinski, H., Spies, T., Phillips, J.H. & Lanier, L.L. DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells. J. Exp. Med. 192, 1059-1067 (2000).
23. Ravetch, J.V. & Perussia, B. Alternative membrane forms of FcγRIII (CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions. J. Exp. Med. 170, 481-497 (1989).
24. Anderson, P., Caligiuri, M., Ritz, J. & Schlossman, S.F. CD3-negative natural killer cells express ζ TCR as part of a novel molecular complex. Nature 341, 159-162 (1989).
25. Lanier, L.L., Yu, G. & Phillips, J.H. Co-association of CD3ζ with a receptor (CD16) for IgG Fc on human natural killer cells. Nature 342, 803-805 (1989).
26. Kurosaki, T. & Ravetch, J.V. A single amino acid in the glycosyl phosphatidylinositol attachment domain determines the membrane topology of FcγRIII. Nature 342, 805-807 (1989).
27. Lanier, L.L., Yu, G. & Phillips, J.H. Analysis of FcγRIII (CD16) membrane expression and association with CD3ζ and FcERI-γ by site-directed mutation. J. Immunol. 146, 1571-1576 (1991).
28. Zompi, S. et al. The NKG2D receptor triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk-family kinases. Nat. Immunol. advance online publication, 12 May 2003 (doi:10.1038/ni930).
29. Weng, W.-K., Jarvis, L. & LeBien, T.W. Signaling through CD19 activates Vav/mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/phosphatidylinositol 3-kinase complex in human B cell precursors. J. Biol. Chem. 269, 32514-32521 (1994).
30. Shigematsu, H. et al. Role of the vav proto-oncogene product (Vav) in erythropoietin-mediated cell proliferation and phosphatidylinositol 3-kinase activity. J. Biol. Chem. 272, 14334-14340 (1997).
31. Windebank, K.P. et al. Signal transduction during human natural killer cell activation: inositol phosphate generation and regulation by cyclic AMP. J. Immunol. 141, 3951-3957 (1988).
32. Ting, A.T., Karnitz, L.M., Schoon, R.A., Abraham, R.T. & Leibson, P.J. Fcγ receptor activation induces the tyrosine phosphorylation of both phospholipase C (PLC-)-γ1 and PLC-γ2 in natural killer cells. J. Exp. Med. 176, 1751-1755 (1992).
33. Ting, A.T. et al. Interaction between lck and syk family tyrosine kinases in Fcγ receptor-initiated activation of natural killer cells. J. Biol. Chem. 270, 16415-16421 (1995).
34. Billadeau, D.D., Mackie, S.M., Schoon, R.A. & Leibson, P.J. The Rho family guanine nucleotide exchange factor Vav-2 regulates the development of cell-mediated cytotoxicity. J. Exp. Med. 192, 381-391 (2000).
35. Billadeau, D.D. et al. The Vav-Rac1 pathway in cytotoxic lymphocytes regulates the generation of cell-mediated killing. J. Exp. Med. 188, 549-559 (1998).
36. Maddon, P.J. et al. The isolation and nucleotide sequence of a cDNA encoding the cell surface protein T4: a new member of the immunoglobulin gene family. Cell 42, 93-104 (1985).
37. Takayama, H., Trenn, G. & Sitkovsky, M.V. A novel cytotoxic T lymphocyte assay. J. Immunol. Methods 104, 183-190 (1987).
38. Walker, C., Checkel, J., Cammisoli, S., Leibson, P.J. & Gleich, G.J. IL-5 production from NK cells contributes to eosinophil infiltration in a mouse model of allergic inflammation. J. Immunol. 161, 1962-1969 (1998).
39. Pross, H.F., Callewaert, D. & Rubin, P. Assay for NK cell cytotoxicity - their values and pitfalls. in Immunobiology of Natural Killer Cells Vol. 1 (eds. Lotzova, E. & Herberman, R.B.) 2-20 (CRC, Boca Raton, Florida, 1986).